Sort by
Refine Your Search
-
these responses can be harnessed therapeutically. Current research integrates advanced immunophenotyping, systems immunology, single-cell multi-omics, viral genomics, and functional immune assays to dissect
-
profile Applicants should hold a PhD in ecology, molecular ecology, genomics, microbiology, bioinformatics, environmental science, or a related discipline. We seek candidates with experience in several
-
working environment and place strong emphasis on good relationships between colleagues and students. We therefore seek candidates with an open, constructive, and collaborative approach. Who we
-
strategies. The position is available from 1 November 2026 or soon thereafter. The position is within the research section Monogastric Nutrition . The position We seek a highly qualified candidate with a
-
of these experiments. As part of this, we have developed new algorithms and a completely new web-based platform – EasyNMR - for performing such modelling/simulations. With this position, we seek to strengthen
-
this position, we seek to strengthen the platform by embedding/developing additional tools for data processing and analysis. The starting point for the developments will be our EasyNMR platform (see
-
patterns of consumer change over time. We therefore seek to welcome another team member to complement the team and contribute to this goal, with some or many of the competences and qualifications outlined
-
of adipogenesis Experience with chromatin conformation methods (e.g., Hi-C, Micro-C or related approaches) Experience with genome-wide and chromatin architecture-related techniques (e.g., sequencing-based assays
-
will continue beyond this date. The position is expected to begin in the fall of 2026. We seek highly motivated, outstanding independent researchers who will work in Prof. Chael’s interdisciplinary group
-
(confocal, electron microscopy and spatial omics) on samples. Using Seahorse and related assays to assess the impact of genome editing and drug treatment on the metabolic activity of pre-clinical models